Association of cystatin C with adverse outcomes

Magdalena Madero1, Mark J Sarnak

  • 1Division of Nephrology, Instituto Nacional de Cardiología Ignacio Chávez, México City, Mexico.

Insights

Cystatin C effectively identifies mild kidney disease risks for mortality and cardiovascular disease (CVD). This marker shows associations even within normal kidney function ranges, aiding in risk assessment for older adults.

Area of Science:

  • Biomarkers in Nephrology
  • Cardiovascular Risk Assessment
  • Geriatric Medicine

Background:

  • Cystatin C is a protein produced by all nucleated cells, influenced by factors beyond kidney function.
  • Creatinine is a commonly used marker for estimating glomerular filtration rate (GFR), but its accuracy can be affected by muscle mass.
  • Understanding the determinants and clinical utility of cystatin C is crucial for accurate risk stratification.

Purpose of the Study:

  • To review recent studies on cystatin C determinants.
  • To analyze the relationship between cystatin C and mortality, cardiovascular disease (CVD), and noncardiovascular outcomes.
  • To compare the predictive value of cystatin C with creatinine.

Main Methods:

  • Review of recent epidemiological and cohort studies.
  • Analysis of associations between cystatin C levels and demographic characteristics.
  • Correlation of cystatin C with measured glomerular filtration rate (GFR).

Main Results:

  • Cystatin C is associated with demographic factors, independent of GFR, though to a lesser extent than creatinine.
  • In chronic kidney disease (CKD) patients, cystatin C strongly correlates inversely with GFR, confirming its role as a kidney function measure.
  • Cohort studies, especially in older adults, show cystatin C linearly associates with mortality and CVD/non-CVD outcomes, unlike creatinine which is more specific to advanced kidney disease.

Conclusions:

  • Cystatin C effectively identifies increased risk of mortality and non-CVD outcomes associated with mild kidney disease.
  • Changes in kidney function, as measured by cystatin C even within normal ranges, predict subsequent CVD and all-cause mortality in older adults.
  • Future research should explore cystatin C's potential to enhance medical decision-making and improve patient outcomes.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...